Latest news
Almirall taps CrystalO's AI platform to discover ion channel drugs for skin disease - AllSciAllSci · Mon, 10 Aug 2026 16:51:48 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSciAllSci · Mon, 10 Aug 2026 16:50:24 GMTBeOne and Revolution Medicines partner on RAS(ON) inhibitor combinations in Asia - AllSciAllSci · Mon, 10 Aug 2026 16:11:22 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSciAllSci · Mon, 10 Aug 2026 14:22:58 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSciAllSci · Mon, 10 Aug 2026 13:57:16 GMTAcurx and Leiden Researchers Seek 3D Structure to Guide MRSA Antibiotics - Stock TitanStock Titan · Mon, 10 Aug 2026 12:01:00 GMT